You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 3, March 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (87)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Surgical Oncology
 •Endocrine Diseases
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic

Sentinel Lymphadenectomy in Thyroid Malignant Neoplasms

Pond R. Kelemen, MD; Andre J. Van Herle, MD; Armando E. Giuliano, MD

Arch Surg. 1998;133:288-292.

Background  Lymph node metastases for well-differentiated thyroid cancer are associated with high recurrence rates. Surgical options consist of blind nodal sampling, "berry-picking"procedures, and modified radical neck dissections. Sentinel lymph node dissection (SLND) has been described by our institution for melanoma and breast cancer. We have investigated the feasibility of SLND for thyroid cancer.

Design  From August 1994 to October 1996 we investigated the technique of intraoperative lymphatic mapping and SLND in 17 patients undergoing surgical management of a suspicious thyroid nodule not accompanied by palpable cervical adenopathy.

Setting  Patients were referred from endocrinologists in community and academic practices. Procedures were performed in a community hospital.

Patients  There were 14 women and 3 men, ranging in age from 22 to 69 years (median, 48 years).

Interventions  At surgery, we exposed the thyroid lobe and used a tuberculin syringe to inject 0.1 to 0.8 mL of 1.0% isosulfan blue dye (mean, 0.5 mL) directly into the thyroid mass. Within seconds the blue dye passed along the lymphatics to the sentinel lymph node, which was then excised. Nodes were examined by routine processing and keratin immunohistochemical analysis to detect micrometastasis.

Main Outcome Measures  The feasibility of lymphatic mapping in determining primary drainage of suspicious thyroid nodules.

Results  Lymphatic mapping and SLND was followed by total thyroidectomy, except in 1 patient who underwent lobectomy for benign disease. Of the 17 nodules, 12 were ultimately diagnosed as thyroid carcinoma, 3 were follicular adenomas, and 2 were colloid nodules. Tumor sizes ranged from 0.8 to 4.0 cm. Lymphatic mapping was unsuccessful in 2 patients, whose lymphatics mapped to the retrosternum. All of the sentinel lymph nodes were paratracheal except in 2 women who also had jugular nodes that stained blue. Five (42%) of the 12 tumor nodules were associated with positive sentinel lymph nodes. Central neck dissections were performed in 5 patients; in 2 instances (17%), the sentinel node was the only tumor-bearing lymph node.

Conclusions  This is the first report of SLND for thyroid carcinoma. Our preliminary findings indicate that SLND can detect nonpalpable nodal metastasis with the same ease as in melanoma and breast cancer. The clinical significance of this technique in thyroid cancer remains to be determined.


From the John Wayne Cancer Institute at Saint John's Health Center, Santa Monica (Drs Kelemen and Giuliano) and Section of Endocrinology, University of California, Los Angeles (Drs Van Herle and Giuliano), Los Angeles, Calif.


RELATED ARTICLE

Sentinel Lymphadenectomy in Thyroid Malignant Neoplasms—Invited Commentary
Clive S. Grant
Arch Surg. 1998;133(3):292.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
Chen et al.
CA Cancer J Clin 2006;56:292-309.
ABSTRACT | FULL TEXT  

Historical Review of Lymphatic Mapping in Gastrointestinal Malignancies
Saha et al.
Ann. Surg. Oncol. 2004;11:245S-249S.
ABSTRACT | FULL TEXT  

Incidence of Metastatic Well-Differentiated Thyroid Cancer in Cervical Lymph Nodes
Wang et al.
Arch Otolaryngol Head Neck Surg 2004;130:110-113.
ABSTRACT | FULL TEXT  

Recombinant TSH-Stimulated, Radioguided Differentiated Thyroid Carcinoma Surgery
Spieth et al.
Clin Med Res 2003;1:53-56.
ABSTRACT | FULL TEXT  

Molecular Lymphatic Mapping of the Sentinel Lymph Node
Taback et al.
Am. J. Pathol. 2002;161:1153-1161.
ABSTRACT | FULL TEXT  

Blue Urticaria: A Previously Unreported Adverse Event Associated With Isosulfan Blue
Sadiq et al.
Arch Surg 2001;136:1433-1435.
ABSTRACT | FULL TEXT  

A revolution in surgical oncology: sentinel lymph node biopsy
Ell
Imaging 2001;13:197-205.
ABSTRACT | FULL TEXT  

Molecular Staging of Early Colon Cancer on the Basis of Sentinel Node Analysis: A Multicenter Phase II Trial
Bilchik et al.
JCO 2001;19:1128-1136.
ABSTRACT | FULL TEXT  

Indications for Bilateral Modified Radical Neck Dissection in Patients With Papillary Carcinoma of the Thyroid
Ohshima et al.
Arch Surg 2000;135:1194-1198.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.